Insiders · ANRO

ANRO insider transactions

Alto Neuroscience Inc. (ANRO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ANRO

• 17d
  SEC Form 4 filed by Director Miller Andrew Craig

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 17d
  SEC Form 3 filed by new insider Miller Andrew Craig

  3 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 31d
  PRESIDENT AND CEO Etkin Amit gifted 400,000 shares, decreasing direct ownership by 32% to 833,949 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Dreyfus Andrew

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 103d
  PRESIDENT AND CEO Etkin Amit covered exercise/tax liability with 6,227 shares, decreasing direct ownership by 0.50% to 1,233,949 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 103d
  CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad covered exercise/tax liability with 2,806 shares, decreasing direct ownership by 10% to 24,060 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 305d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 305d
  SEC Form 3 filed by new insider Sanchez Ramiro

  3 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Dreyfus Andrew

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 704d
  CHIEF MEDICAL OFFICER Savitz Adam bought $190,833 worth of shares (15,000 units at $12.72) (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 754d
  SEC Form 4 filed by Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 754d
  SEC Form 3 filed by new insider Hanley Jr. Michael Conick

  3 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 805d
  Smith Nicholas Conrad bought $100,628 worth of shares (6,150 units at $16.36), increasing direct ownership by 30% to 26,866 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 825d
  SEC Form 4 filed by Radhakrishnan Maha

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 825d
  SEC Form 3 filed by new insider Radhakrishnan Maha

  3 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 831d
  Apeiron Investment Group Ltd. converted options into 926,539 shares (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  SEC Form 4 filed by Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  Smith Nicholas Conrad was granted 19,153 shares, increasing direct ownership by 1,225% to 20,716 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  Etkin Amit was granted 34,711 shares, increasing direct ownership by 3% to 1,240,176 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)